Literature DB >> 6379132

Diagnosis of pleural malignant mesothelioma in life--a practical approach.

D Whitaker, K B Shilkin.   

Abstract

This review documents a practical approach to the pathological diagnosis of pleural malignant mesothelioma based on the closed needle biopsy and effusion cytology, thus avoiding the need to resort to open surgery. Tissue diagnosis is often difficult, and the pathologist's opinion may be influenced by a consideration of three factors: the clinical setting; the adequacy and availability of specimens; and the criteria for assessment and interpretation of these. The level of confidence with which a tissue diagnosis of mesothelioma can be established using limited material depends on there being an appropriate clinical background including a history of asbestos exposure. Without this, the diagnosis should be a qualified or tentative one. For an adequate tissue sample to be obtained, the closed needle biopsy procedure is best performed by an experienced operator. All aspirated pleural effusions should be forwarded for cytological evaluation. In addition to conventional morphological studies, adequate samples permit ancillary tests to be carried out. A combined interpretive approach utilizing both histopathology and cytology is recommended in order to increase the accuracy of the diagnosis.

Entities:  

Mesh:

Year:  1984        PMID: 6379132     DOI: 10.1002/path.1711430303

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  17 in total

Review 1.  Statement on malignant mesothelioma in the United Kingdom.

Authors: 
Journal:  Thorax       Date:  2001-04       Impact factor: 9.139

2.  Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.

Authors:  Emin Tamer Elkiran; Mehmet Ali Kaplan; Alper Sevinc; Sercan Aksoy; Umut Demirci; Mesut Seker; Hakan Harputluoglu; Nuriye Yildirim Ozdemir; Feridun Isik; Arife Ulas; Mevlude Inanc; Ulku Yalcintas Arslan; Gamze Gokoz Dogu; Abdurrahman Isikdogan; Suleyman Buyukberber
Journal:  Med Oncol       Date:  2012-06-22       Impact factor: 3.064

3.  Evaluation of impact of immunocytochemical techniques in cytological diagnosis of neoplastic effusions.

Authors:  A Linari; G Bussolati
Journal:  J Clin Pathol       Date:  1989-11       Impact factor: 3.411

Review 4.  Malignant mesothelioma.

Authors:  R Rudd
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

5.  New marker for mesothelioma: an immunoperoxidase study.

Authors:  A Donna; P G Betta; D Bellingeri; A Marchesini
Journal:  J Clin Pathol       Date:  1986-09       Impact factor: 3.411

Review 6.  Lung cancer * 8: Management of malignant mesothelioma.

Authors:  C Parker; E Neville
Journal:  Thorax       Date:  2003-09       Impact factor: 9.139

7.  Epithelial membrane antigen and cytokeratin expression by meningiomas: an immunohistological study.

Authors:  J M Theaker; K C Gatter; M M Esiri; K A Fleming
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

8.  Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma.

Authors:  A R Gibbs; R Harach; J C Wagner; B Jasani
Journal:  Thorax       Date:  1985-02       Impact factor: 9.139

Review 9.  Pathogenesis of pleurisy, pleural fibrosis, and mesothelial proliferation.

Authors:  A Herbert
Journal:  Thorax       Date:  1986-03       Impact factor: 9.139

10.  The use of vimentin antibodies in the diagnosis of malignant mesothelioma.

Authors:  B Jasani; R E Edwards; N D Thomas; A R Gibbs
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.